Table 1.
Analysis of 1433 isolated pancreatic metastases from RCC (N = number of cases with adequate documentation).
| Variable | Data | % |
|---|---|---|
| Casuistic case reports | 573 | |
| Renal cell carcinoma | ||
| EXSide affected: left:right:bil. (N = 476) | 253:216:7 | 53.1:45.4:1.5 |
| TNM category: T (N = 87) | T1 13; T2 35, T3 37, T4 2 | 12.8, 40.2, 42.5, 2.3 |
| TNM category: N (N = 79) | N0 73; N1 6 | 92.8; 7.2 |
| TNM category: M (N = 68) | M0 67; M1 1 | 97.2; 2.8 |
| Histology clear cell (N = 420) | 411 | 97.8 |
| Pancreatic metastases | ||
| Age at diagnosis (N = 833) EX | 63.7 (SD 9.9) | |
| Synchron.-metachron. (N = 839) | 62:777 | 7.4:92.6 |
| Interval to metastasis (N = 855) | 9.6 (SD 6.5) | |
| Solitary/multiple (N = 733) EX | 451; 282 | 63.6; 36.4 |
| Number of multiple metastases (N = 115) |
3.1 (SD 1.5) | |
| Site: head; corpus; cauda; multiple (N = 419) |
141; 67; 85; 129 | 33.4; 15.9; 20.1; 30.6 |
| Size (mm), (N = 417) | 32.6 (SD 20.5) | |
| LN metastasis (N = 517) | 32 | 6.2 |
| Outcome of surgery | ||
| Cum. 5-year survival rate (N = 432) | 75.7 | |
| Recurrent disease (N = 301) | 125 | 41.5 |